Home Healthcare Healthcare Services Asia Pacific Cell and Gene Therapy Manufacturing QC Market

Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-Commercial/R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-House Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Vector Production, Others), By Process (Upstream Processes, Downstream Processes), By End User (Pharmaceutical Companies, Biopharmaceutical/Biotechnological Companies, others), By Technology Type (FACS, ELISA, Others), By Country (China, Japan, India, Korea, Australia, Others), Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
  7. APAC Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. China
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Korea
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. Japan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. India
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Australia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  8. Competitive Landscape
    1. Asia Pacific Cell and Gene Therapy Manufacturing QC Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Lonza
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pharmaron
    3. Eurofins Scientific
    4. Merck KGaA
    5. Catalent Inc.
    6. Charles River Laboratories
    7. Thermo Fisher Scientific Inc.
    8. WuXi AppTec
    9. BioAgilytix Labs
    10. Alcami Corporation
    11. IQVIA Inc.
    12. SGS Société Générale de Surveillance SA
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  12. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.